---
figid: PMC6387042__ijms-20-00755-g001
figtitle: Mammalian or mechanistic target of rapamycin (mTOR) complexes and signaling
  pathway of mTORC1 and mTORC2
organisms:
- Homo sapiens
pmcid: PMC6387042
filename: ijms-20-00755-g001.jpg
figlink: /pmc/articles/PMC6387042/figure/ijms-20-00755-f001/
number: F1
caption: The mammalian or mechanistic target of rapamycin (mTOR) complexes and signaling
  pathway of mTORC1 and mTORC2. mTORC1 is responsive to nutrients, hormones, amino
  acids, hypoxia and growth factors, while mTORC2 responds to growth factors. mTORC1
  and mTORC2 share common subunits of mTOR kinase, mLST8, DEPTOR (DEP domain-containing
  mTOR-interacting protein), Tel 2 and Tti 1. mTORC1 additionally binds with RAPTOR
  (Regulatory-associated protein of mTOR) and PRAS40 (Proline-rich substrate of 40
  kDa), and mTORC2 combines with RICTOR and mSIN1 (Mammalian stress-activated protein
  kinase interacting protein 1) as well as Protor and PRR5 (Proline-rich protein 5).
  mTORC1 is regulated by PI3K/Akt (Phosphoinositide 3-kinase/serine-threonine protein
  kinase) and Ras-MAPK (Mitogen activated protein kinase) signaling pathways. mTORC1
  regulates protein translation and synthesis of nucleotide lipid via 4E-BP1 and S6K1
  and downstream effectors. mTORC1 also activates STAT3 (Signal transducer and activator
  of transcription), HIF-1α (Hypoxia-inducible factor 1α) and PP2A (Protein phosphatase
  2A) in tumorigenesis. mTORC2 regulates SGK (Serum glucose kinase) and PKC (Protein
  kinase C) to promote cell survival, cytoskeleton reorganization and cell migration.
  mTORC2 is negatively modulated by mTORC1 via different feedback loops mediated by
  IRS (insulin receptor substrate) or Grb10. mTORC1 and mTORC2 can both contribute
  to turmorigenesis through different mechanisms [,].
papertitle: mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting
  Therapy.
reftext: Tian Tian, et al. Int J Mol Sci. 2019 Feb;20(3):755.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9418851
figid_alias: PMC6387042__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6387042__F1
ndex: 7ae395b7-df04-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6387042__ijms-20-00755-g001.html
  '@type': Dataset
  description: The mammalian or mechanistic target of rapamycin (mTOR) complexes and
    signaling pathway of mTORC1 and mTORC2. mTORC1 is responsive to nutrients, hormones,
    amino acids, hypoxia and growth factors, while mTORC2 responds to growth factors.
    mTORC1 and mTORC2 share common subunits of mTOR kinase, mLST8, DEPTOR (DEP domain-containing
    mTOR-interacting protein), Tel 2 and Tti 1. mTORC1 additionally binds with RAPTOR
    (Regulatory-associated protein of mTOR) and PRAS40 (Proline-rich substrate of
    40 kDa), and mTORC2 combines with RICTOR and mSIN1 (Mammalian stress-activated
    protein kinase interacting protein 1) as well as Protor and PRR5 (Proline-rich
    protein 5). mTORC1 is regulated by PI3K/Akt (Phosphoinositide 3-kinase/serine-threonine
    protein kinase) and Ras-MAPK (Mitogen activated protein kinase) signaling pathways.
    mTORC1 regulates protein translation and synthesis of nucleotide lipid via 4E-BP1
    and S6K1 and downstream effectors. mTORC1 also activates STAT3 (Signal transducer
    and activator of transcription), HIF-1α (Hypoxia-inducible factor 1α) and PP2A
    (Protein phosphatase 2A) in tumorigenesis. mTORC2 regulates SGK (Serum glucose
    kinase) and PKC (Protein kinase C) to promote cell survival, cytoskeleton reorganization
    and cell migration. mTORC2 is negatively modulated by mTORC1 via different feedback
    loops mediated by IRS (insulin receptor substrate) or Grb10. mTORC1 and mTORC2
    can both contribute to turmorigenesis through different mechanisms [,].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PTEN
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TELO2
  - ETV7
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TTI1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - TSC2
  - EPHB2
  - MAPK1
  - MAPK3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - RHEB
  - RHEBP1
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - GRB10
  - DEPTOR
  - ACAT1
  - AKT1S1
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - SGK1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - PTPA
  - STAT3
  - HIF1A
  - EIF4EBP1
  - EIF4E
  - EIF4E2
  - EIF4E3
  - EIF4B
  - ELF3
  - EIF3A
  - TLR1
  - Amino acids
  - PP2A
  - Nucleotide
  - Hypoxia
  - HIF-la
---
